234 related articles for article (PubMed ID: 35802815)
21. Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: A retrospective multicenter study.
Dal MS; Batgi H; Erkurt MA; Hindilerden IY; Kuku I; Kurtoglu E; Kaya E; Besisik SK; Berber I; Nalcaci M; Ulas T; Altuntas F
Transfus Apher Sci; 2021 Oct; 60(5):103243. PubMed ID: 34420879
[TBL] [Abstract][Full Text] [Related]
22. An alternative for extracorporeal photopheresis: 8-methoxypsoralen and UVA-treated leucocytes from allogeneic donors improve graft-versus-host disease in mice.
Budde H; Papert S; Reichardt HM; Jarry H; Riggert J; Legler TJ
Vox Sang; 2018 Nov; 113(8):803-810. PubMed ID: 30353554
[TBL] [Abstract][Full Text] [Related]
23. Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report.
Berger M; Pessolano R; Albiani R; Asaftei S; Barat V; Carraro F; Biasin E; Madon E; Fagioli F
J Pediatr Hematol Oncol; 2007 Oct; 29(10):678-87. PubMed ID: 17921848
[TBL] [Abstract][Full Text] [Related]
24. Extracorporeal photopheresis for graft-vs-host disease: A literature review and treatment guidelines proposed by the Nordic ECP Quality Group.
Nygaard M; Wichert S; Berlin G; Toss F
Eur J Haematol; 2020 May; 104(5):361-375. PubMed ID: 31908057
[TBL] [Abstract][Full Text] [Related]
25. Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD).
Mankarious M; Matthews NC; Snowden JA; Alfred A
Front Immunol; 2020; 11():81. PubMed ID: 32082329
[TBL] [Abstract][Full Text] [Related]
26. Spectacular and Prompt Response to Extracorporeal Photopheresis for Refractory Cutaneous Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report.
Spałek A; Grygoruk-Wiśniowska I; Gruenpeter K; Panz-Klapuch M; Helbig G
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556924
[TBL] [Abstract][Full Text] [Related]
27. Extracorporeal photopheresis as a promising strategy for the treatment of graft-versus-host disease after CAR T-cell therapy.
Han H; Wang L; Ding Y; Neuber B; Hückelhoven-Krauss A; Lin M; Yao H; Chen Q; Sauer T; Schubert ML; Guo Z; Müller-Tidow C; Schmitt M; Schmitt A
Blood Adv; 2024 Jun; 8(11):2675-2690. PubMed ID: 38359409
[TBL] [Abstract][Full Text] [Related]
28. Care for patients undergoing extracorporeal photopheresis to treat chronic graft-versus-host disease: review of the evidence.
Woltz P; Castro K; Park BJ
Clin J Oncol Nurs; 2006 Dec; 10(6):795-802. PubMed ID: 17193945
[TBL] [Abstract][Full Text] [Related]
29. Extracorporeal photopheresis: Is one ounce of blood enough? Case reports.
Kumukova I; Kurnikova E; Trakhtman P
Pediatr Blood Cancer; 2024 Mar; 71(3):e30800. PubMed ID: 38105463
[TBL] [Abstract][Full Text] [Related]
30. Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation.
Brownback KR; Simpson SQ; Pitts LR; Polineni D; McGuirk JP; Ganguly S; Aljitawi OS; Lin TL; Singh A; Abhyankar S
J Clin Apher; 2016 Aug; 31(4):347-52. PubMed ID: 26031713
[TBL] [Abstract][Full Text] [Related]
31. Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation.
Messina C; Locatelli F; Lanino E; Uderzo C; Zacchello G; Cesaro S; Pillon M; Perotti C; Del Fante C; Faraci M; Rivabella L; Calore E; De Stefano P; Zecca M; Giorgiani G; Brugiolo A; Balduzzi A; Dini G; Zanesco L; Dall'Amico R
Br J Haematol; 2003 Jul; 122(1):118-27. PubMed ID: 12823353
[TBL] [Abstract][Full Text] [Related]
32. Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation.
Shaughnessy PJ; Bolwell BJ; van Besien K; Mistrik M; Grigg A; Dodds A; Prince HM; Durrant S; Ilhan O; Parenti D; Gallo J; Foss F; Apperley J; Zhang MJ; Horowitz MM; Abhyankar S
Bone Marrow Transplant; 2010 Jun; 45(6):1068-76. PubMed ID: 19915634
[TBL] [Abstract][Full Text] [Related]
33. The role of the extracorporeal photopheresis in the management of the graft-versus-host disease.
Kaloyannidis P; Mallouri D
Transfus Apher Sci; 2012 Apr; 46(2):211-9. PubMed ID: 22123355
[TBL] [Abstract][Full Text] [Related]
34. Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: A multicenter experience.
Batgi H; Dal MS; Erkurt MA; Kuku I; Kurtoglu E; Hindilerden IY; Kaya E; Berber I; Ulas T; Altuntas F
Transfus Apher Sci; 2021 Oct; 60(5):103242. PubMed ID: 34420882
[TBL] [Abstract][Full Text] [Related]
35. Extracorporeal Photopheresis in Graft-versus-Host Disease.
Asensi Cantó P; Sanz Caballer J; Solves Alcaína P; de la Rubia Comos J; Gómez Seguí I
Transplant Cell Ther; 2023 Sep; 29(9):556-566. PubMed ID: 37419324
[TBL] [Abstract][Full Text] [Related]
36. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents.
Buder K; Zirngibl M; Bapistella S; Meerpohl JJ; Strahm B; Bassler D; Weitz M
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD009898. PubMed ID: 35679154
[TBL] [Abstract][Full Text] [Related]
37. Steroid-sparing effect of extracorporeal photopheresis in the therapy of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Ussowicz M; Musiał J; Mielcarek M; Tomaszewska A; Nasiłowska-Adamska B; Kałwak K; Gorczyńska E; Mariańska B; Chybicka A
Transplant Proc; 2013 Nov; 45(9):3375-80. PubMed ID: 24182819
[TBL] [Abstract][Full Text] [Related]
38. Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden.
Schain F; Boissin C; Laczik T; Fedeli S; Remberger M; Blennow O; Dykes J; Eich T; Jones C; Mattsson J; Berlin G
Transfus Apher Sci; 2023 Jun; 62(3):103705. PubMed ID: 36967367
[TBL] [Abstract][Full Text] [Related]
39. Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects.
Wang L; Ni M; Hückelhoven-Krauss A; Sellner L; Hoffmann JM; Neuber B; Luft T; Hegenbart U; Schönland S; Kleist C; Sill M; Chen BA; Wuchter P; Eckstein V; Krüger W; Hilgendorf I; Yerushalmi R; Nagler A; Müller-Tidow C; Ho AD; Dreger P; Schmitt M; Schmitt A
Front Immunol; 2018; 9():2207. PubMed ID: 30349527
[TBL] [Abstract][Full Text] [Related]
40. The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host disease.
Alsuliman T; Magro L; Coiteux V; Gauthier J; Srour M; Lionet A; Beauvais D; Yakoub-Agha I
Curr Res Transl Med; 2020 Apr; 68(2):71-76. PubMed ID: 31631014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
